These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22935368)

  • 41. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
    Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biophysics and Thermodynamics: The Scientific Building Blocks of Bio-inspired Drug Delivery Nano Systems.
    Demetzos C
    AAPS PharmSciTech; 2015 Jun; 16(3):491-5. PubMed ID: 25899798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanomaterial Drug Products: Manufacturing and Analytical Perspectives.
    Sayes CM; Aquino GV; Hickey AJ
    AAPS J; 2017 Jan; 19(1):18-25. PubMed ID: 27822601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward greener analytical techniques for the absolute quantification of peptides in pharmaceutical and biological samples.
    Van Eeckhaut A; Mangelings D
    J Pharm Biomed Anal; 2015 Sep; 113():181-8. PubMed ID: 25864956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Raman mapping of pharmaceuticals.
    Gordon KC; McGoverin CM
    Int J Pharm; 2011 Sep; 417(1-2):151-62. PubMed ID: 21194560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-Molecule Characterization of Drug Delivery Systems.
    Okay S
    Assay Drug Dev Technol; 2020 Jan; 18(1):56-63. PubMed ID: 31573322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds.
    Kankala RK; Chen BQ; Liu CG; Tang HX; Wang SB; Chen AZ
    Int J Nanomedicine; 2018; 13():4227-4245. PubMed ID: 30087558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Particles in therapeutic protein formulations, Part 1: overview of analytical methods.
    Zölls S; Tantipolphan R; Wiggenhorn M; Winter G; Jiskoot W; Friess W; Hawe A
    J Pharm Sci; 2012 Mar; 101(3):914-35. PubMed ID: 22161573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced structural characterisation of pharmaceuticals using nano-thermal analysis (nano-TA).
    Goh CF; Lane ME
    Adv Drug Deliv Rev; 2022 Jan; 180():114077. PubMed ID: 34896130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analytical lessons learned from selected therapeutic protein drug comparability studies.
    Federici M; Lubiniecki A; Manikwar P; Volkin DB
    Biologicals; 2013 May; 41(3):131-47. PubMed ID: 23146362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the structural properties of bioactive-loaded nanocarriers with modern analytical tools.
    Rostamabadi H; Falsafi SR; Assadpour E; Jafari SM
    Compr Rev Food Sci Food Saf; 2020 Nov; 19(6):3266-3322. PubMed ID: 33337066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atomic pair distribution function: a revolution in the characterization of nanostructured pharmaceuticals.
    Billinge SJ
    Nanomedicine (Lond); 2015; 10(16):2473-5. PubMed ID: 26293547
    [No Abstract]   [Full Text] [Related]  

  • 54. Fractal analysis as a complementary approach to predict the stability of drug delivery nano systems in aqueous and biological media: a regulatory proposal or a dream?
    Demetzos C; Pippa N
    Int J Pharm; 2014 Oct; 473(1-2):213-8. PubMed ID: 25016981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orthogonal and complementary measurements of properties of drug products containing nanomaterials.
    Simon CG; Borgos SE; Calzolai L; Nelson BC; Parot J; Petersen EJ; Roesslein M; Xu X; Caputo F
    J Control Release; 2023 Feb; 354():120-127. PubMed ID: 36581261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artifacts in chromatography: an overview.
    Middleditch BS; Zlatkis A
    J Chromatogr Sci; 1987 Dec; 25(12):547-51. PubMed ID: 3323218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of morphology transitions in diffusion-controlled systems.
    Ben-Jacob E; Garik P; Mueller T; Grier D
    Phys Rev A Gen Phys; 1988 Aug; 38(3):1370-1380. PubMed ID: 9900513
    [No Abstract]   [Full Text] [Related]  

  • 58. Red blood cells: a potential delivery system.
    Chen M; Leng Y; He C; Li X; Zhao L; Qu Y; Wu Y
    J Nanobiotechnology; 2023 Aug; 21(1):288. PubMed ID: 37608283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review.
    Viegas C; Patrício AB; Prata JM; Nadhman A; Chintamaneni PK; Fonte P
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanoparticle-Based Delivery Systems for Vaccines.
    Bezbaruah R; Chavda VP; Nongrang L; Alom S; Deka K; Kalita T; Ali F; Bhattacharjee B; Vora L
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.